Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2019 · 10-Q
Revenue$247.36M$247.36M+5.7% vs Q3 2018 Net Income-$8.48M-$8.48MN/M vs Q3 2018 EPS Diluted$0.35$0.35N/M vs Q3 2018 Gross Profit$111,175,000−0.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$58,164,000−11.1% Free Cash Flowderived$28,921,000−25.5% Margins · derivedGross margin44.9%−2.6 pt vs Q3 2018
Operating margin11.4%+11.0 pt vs Q3 2018
Net margin-3.4%−0.6 pt vs Q3 2018
ended Dec 29, 2018 · filed Feb 5, 2019 · 38 d after period end